Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of Caspofungin (Cancidas) in Patients With Hematological Malignancies and Concomitant Candidemia
2004-004266-32Phase 4Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Aug 2007
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of caspofungin in candidemia, sponsored by Policlinico Gemelli. Started Aug 2007; status: terminated.
02
Drugs
caspofungin
03
Conditions
candidemia
Beyond the preview
Go deeper on 2004-004266-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004266-32.